Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-28

Clinical Trial Update: A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia [Phase 2]

View source ↗

Summary

Phase II study evaluating pomalidomide in myelofibrosis with myeloid metaplasia completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pomalidomide (Pomalidomide)

Snippet

Sponsor: Celgene | Conditions: Myelofibrosis With Myeloid Metaplasia, Myeloid Metaplasia | Phase 2 | Status: COMPLETED | Results posted: 2013-10-28